---All---
  • ---All---
  • Accession
  • Catalog #

RNF34 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP16633b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP16633b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

RNF34 Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ969K3
Other AccessionQ6AYH3, Q99KR6, Q5E9J6, NP_079402.2, NP_919247.1
ReactivityHuman
PredictedBovine, Mouse, Rat
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW41641 Da

RNF34 Antibody (C-term) - Additional info

Gene ID 80196
Other Names
RNF34; E3 ubiquitin-protein ligase RNF34; Caspase regulator CARP1; Caspases-8 and -10-associated RING finger protein 1; FYVE-RING finger protein Momo; Human RING finger homologous to inhibitor of apoptosis protein; RING finger protein 34; RING finger protein RIFF
Target/Specificity
This RNF34 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 282-311 amino acids from the C-terminal region of human RNF34.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
RNF34 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

RNF34 Antibody (C-term) - Protein Information

Name RNF34
Function
Has E3 ubiquitin-protein ligase activity. Regulates the levels of CASP8 and CASP10 by targeting them for proteasomal degradation. Protects cells against apoptosis induced by TNF Binds phosphatidylinositol 5-phosphate and phosphatidylinositol 3- phosphate
Cellular Location
Nucleus speckle. Endomembrane system; Peripheral membrane protein
Tissue Location
Ubiquitous. Detected in heart, brain, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, colon and leukocytes

RNF34 Antibody (C-term) - Related products

AP16633b: RNF34 Antibody (C-term)

DC02259: Human RNF34 cDNA Clone

AF1937a: RNF34 / RFI (N Terminus) Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The protein encoded by this gene contains a RINF finger, a motif known to be involved in protein-protein and protein-DNA interactions. This protein interacts with DNAJA3/hTid-1, which is a DnaJ protein reported to function as a modulator of apoptosis. Overexpression of this gene in Hela cells was shown to confer the resistance to TNF-alpha induced apoptosis, suggesting an anti-apoptotic function of this protein. This protein can be cleaved by caspase-3 during the induction of apoptosis. Alternatively spliced transcript variants encoding distinct isoforms have been reported.

REFERENCES

Erlbruch, A., et al. Proteomics 10(16):2890-2900(2010) Yang, W., et al. Cell Cycle 7(5):670-682(2008) Yang, W., et al. J. Biol. Chem. 282(5):3273-3281(2007) Konishi, T., et al. Mol. Cancer Ther. 4(5):743-750(2005) Sasaki, S., et al. J. Exp. Clin. Cancer Res. 23(3):507-512(2004)